Menu

Imperial Innovations has access to intellectual property developed at, or associated with, some of the world's leading academic centres: Cambridge University, Oxford University, University College London and Imperial College London.

Across the full range of science subjects, the four universities we have access to have strong claims to be among the best in the world, and are the four leading research intensive universities in Europe (QS University Rankings 2014)

We have proprietary access to technology developed at Imperial College London, through an exclusive Technology Pipeline Agreement, by which the College assigns intellectual property developed by its researchers to Imperial Innovations for the purpose of assessment and commercialisation.

Though we do not have proprietary access to technology developed at Cambridge, Oxford and UCL, we have developed local collaborations and have deep networks and skills that enable us to source opportunities from management teams and from academics. We ensure that intellectual property is appropriately protected and owned by the businesses we invest in, ensuring appropriate rights have been secured from the relevant technology transfer offices.

Imperial College London

Imperial Innovations was originally founded to protect and maximise the value of commercial opportunities arising from research undertaken at Imperial College London. Through our Technology Transfer Office, we have an early opportunity to assess the commercial potential of research from Imperial College London, and can accelerate its development through funding and support. We also provide technology transfer services for the Imperial College London Healthcare NHS Trust and the Northwest London Hospitals Trust, which include Hammersmith, Charing Cross, St Mary's, Northwick Park and Central Middlesex Hospitals. These hospitals work closely with Imperial's medical faculty.

Cambridge Enterprise, Oxford Spinout Equity Management & UCLB

Innovations has collaborations in place with these three organisations, which are responsible for managing equity in spin-out companies from Cambridge University, Oxford University and University College London. Innovations has a history of collaboration with these universities through its work with these organisations.